Metabolic fluxes during strong carbon catabolite repression by malate in Bacillus subtilis.
Commonly glucose is considered to be the only preferred substrate in Bacillus subtilis whose presence represses utilization of other alternative substrates. Because recent data indicate that malate might be an exception, we quantify here the carbon source utilization hierarchy. Based on physiology and transcriptional data during co-utilization experiments with eight carbon substrates, we demonstrate that malate is a second preferred carbon source for B. subtilis, which is rapidly co-utilized with glucose and strongly represses the uptake of alternative substrates. From the different hierarchy and degree of catabolite repression exerted by glucose and malate, we conclude that both substrates might act through different molecular mechanisms. To obtain a quantitative and functional network view of how malate is (co)metabolized, we developed a novel approach to metabolic flux analysis that avoids error-prone, intuitive, and ad hoc decisions on (13)C rearrangements. In particular, we developed a rigorous approach for deriving reaction reversibilities by combining in vivo intracellular metabolite concentrations with a thermodynamic feasibility analysis. The thus-obtained analytical model of metabolism was then used for network-wide isotopologue balancing to estimate the intracellular fluxes. These (13)C-flux data revealed an extraordinarily high malate influx that is primarily catabolized via the gluconeogenic reactions and toward overflow metabolism. Furthermore, a considerable NADPH-producing malic enzyme flux is required to supply the biosynthetically required NADPH in the presence of malate. Co-utilization of glucose and malate resulted in a synergistic decrease of the respiratory tricarboxylic acid cycle flux.
Kleijn
Roelco J
RJ
Institute of Molecular System Biology, ETH Zürich, CH-8093 Zürich, Switzerland.
Buescher
Joerg M
JM
Le Chat
Ludovic
L
Jules
Matthieu
M
Aymerich
Stephane
S
Sauer
Uwe
U
D001412:Bacillus subtilis / Q000187:drug effects* / Q000235:genetics / Q000254:growth & development / Q000378:metabolism*; D002244:Carbon / Q000378:metabolism*; D002247:Carbon Isotopes; D005798:Genes, Bacterial / Q000235:genetics; D005947:Glucose / Q000378:metabolism / Q000494:pharmacology; D042541:Intracellular Space / Q000187:drug effects / Q000378:metabolism; D007553:Isotope Labeling; D008293:Malates / Q000378:metabolism / Q000494:pharmacology*; D013379:Substrate Specificity; D013816:Thermodynamics; D014158:Transcription, Genetic / Q000187:drug effects
D002247:Carbon Isotopes; D008293:Malates; D002244:Carbon; C030298:malic acid; D005947:Glucose